Greenphire Logo

Whether you call them decentralized, hybrid, virtual, technology-enabled studies have empowered patients to participate in clinical research both in the clinic and at home. Never was this as important as during the COVID-19 pandemic and on, with many sponsors and CROs committing to leverage technology to improve the patient experience and improve at-home study visit compliance.

Panel:

  • Zach Hales, Associate Director, Product Management, Greenphire
  • Crain Lipset, Founder, Decentralized trials & research Alliance (DTRA)
  • Michael Bodmann, Sr. Clinical Trial Manager/Sr. Associate Director, Medpace
  • Steve Wimmer, Director of Partnerships, 1nHealth

This session was presented as part of Greenphire's 2021 Patient Convenience Summit. To access all sessions, please click here.

Greenphire, Inc. will use the information you provide above to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.